Raycure Drugs Limited - Company Profile

It is a chemicals public limited company based in U.T. Chandigarh., Chandigarh, India, established in 2006.
2006 U.T. Chandigarh., Chandigarh, India Active
Last Updated:
Access Report
About Raycure Drugs Limited

Raycure Drugs Limited, a active public limited company, was established on 02 January 2006 in U.T. Chandigarh., Chandigarh, India. Engaging in chemical products within the manufacturing sector, it holds CIN: U00304CH2006PLC029458. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

It upholds a compliant status. Its leadership includes Tarsem Kumar Ruby (Director), Veeta Sharma (Director), Sanjay Jhamb (Additional Director). Past directors included Sat Parkash Mittal. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sco 859, Nac Manimajra,U.T. Chandigarh., U.T. Chandigarh., Chandigarh.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U00304CH2006PLC029458

  • Registration Number

    029458

  • Incorporation Date

    02 January 2006

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Chandigarh

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 20 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** -16.88%
  • Profit Growth **** 42.58%
  • Ebitda **** 85.61%
  • Net Worth -356.61%
  • Total Assets **** 20.71%
Company report

Raycure Drugs Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Raycure Drugs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Raycure Drugs Limited?
Current Directors
Name Designation Appointment Date Status
Tarsem Kumar Ruby Director 02 Jan 2006 Current
Veeta Sharma Director 02 Jan 2006 Current
Sanjay Jhamb Additional Director 31 Aug 2020 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 31 Aug 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Raycure Drugs.

Raycure Drugs Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 16.88% decrease. The company also saw a substantial improvement in profitability, with a 42.58% increase in profit. The company's net worth observed a substantial decline by a decrease of 356.61%.

Raycure Drugs revenue growth over time
Raycure Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -16.88%
*******
*******
*******
*******
Revenue from Operations
*******
 -15.10%
*******
*******
*******
*******
Total Assets
*******
 20.71%
*******
*******
*******
*******
Profit or Loss
*******
 42.58%
*******
*******
*******
*******
Net Worth
*******
 -356.61%
*******
*******
*******
*******
EBITDA
*******
 85.61%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Raycure Drugs?

In 2017, Raycure Drugs had a promoter holding of 92.00% and a public holding of 8.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Raycure Drugs?

Unlock and access historical data on people associated with Raycure Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Raycure Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raycure Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Raycure Drugs
Recent Activity within the Organization
  • Annual General Meeting

    Raycure Drugs Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Raycure Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was recorded as a recent event.

  • Director Appointment

    Progress on Sanjay Jhamb was appointed as a Additional Director was appointed as a Additional Director on 31 Aug 2020 & has been associated with this company since 5 years 6 months . was documented.

  • Director Appointment

    Tarsem Kumar Ruby was appointed as a Director was appointed as a Director on 02 Jan 2006 & has been associated with this company since 20 years 2 months . was recorded as a recent event.

  • Director Appointment

    The activity Veeta Sharma was appointed as a Director was appointed as a Director on 02 Jan 2006 & has been associated with this company since 20 years 2 months . was completed.

  • Company Incorporation

    Progress on Raycure Drugs Limited was registered on 02 Jan 2006 with Roc Chandigarh & aged 20 years 2 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Raycure Drugs Limited?

The CIN of Raycure Drugs Limited is U00304CH2006PLC029458.

Where is Raycure Drugs Limited headquartered?

Raycure Drugs Limited is headquartered at Sco 859, Nac Manimajra,U.T. Chandigarh., U.T. Chandigarh., Chandigarh.

When was Raycure Drugs Limited incorporated?

Raycure Drugs Limited was incorporated on 02 January 2006.

Who are the current directors of Raycure Drugs Limited?

The current directors of Raycure Drugs Limited are

What is the primary industry of Raycure Drugs Limited?

The primary industry of Raycure Drugs Limited is Manufacturing.

Is Raycure Drugs Limited a listed company?

Raycure Drugs Limited is unlisted.

What is the capital structure of Raycure Drugs Limited?

The authorized capital of Raycure Drugs Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

What is the compliance status of Raycure Drugs Limited?

The compliance status of Raycure Drugs Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available